Loading...
•
Mar 27, 2021
Charles River Labs Q1 2021 Earnings Report
Revenue increased by 16.6% and GAAP earnings per share increased by 17.6%.
Key Takeaways
Charles River Laboratories reported a strong first quarter in 2021, with revenue reaching $824.6 million, a 16.6% increase compared to the first quarter of 2020. GAAP earnings per share were $1.20, a 17.6% increase year-over-year, and non-GAAP earnings per share were $2.53, a 37.5% increase year-over-year. The company also updated its 2021 guidance, reflecting confidence in continued client demand.
First-quarter revenue reached $824.6 million, a 16.6% increase from the previous year.
GAAP earnings per share were $1.20, up 17.6% from Q1 2020.
Non-GAAP earnings per share were $2.53, a 37.5% increase from the same period last year.
The company updated its 2021 guidance due to strong first-quarter performance and anticipated continued client demand.
Revenue by Segment
Forward Guidance
Charles River Laboratories updated its 2021 financial guidance, increasing revenue growth and non-GAAP EPS expectations due to a strong first quarter and continued robust client demand.
Positive Outlook
- Revenue growth, reported: 19% – 21%
- Revenue growth, organic: 12% – 14%
- GAAP EPS estimate: $5.95 – $6.20
- Non-GAAP EPS estimate: $9.75 – $10.00
- Free cash flow: ~$435 million
Challenges Ahead
- Contribution from acquisitions: (4.5%) – (5.0%)
- Unfavorable impact of foreign exchange: ~(2.5%)
- Acquisition-related amortization: $2.15 – $2.40
- Acquisition-related adjustments: $0.75 – $0.80
- Other items: ~$0.55
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...